Prescribing trend of tapentadol in a Sydney local health district-Reference-Cited by-同舟云学术

Prescribing trend of tapentadol in a Sydney local health district

Published:2022-07-07 Issue:9 Volume:88 Page:3929-3935
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Brit J Clinical Pharma

Author:

Mirabella Jennifer¹,Ravi Deepa²,Chiew Angela L.¹³^ORCID,Buckley Nicholas A.⁴^ORCID,Chan Betty S.¹³^ORCID

Affiliation:

1. Faculty of Medicine University of New South Wales Randwick NSW Australia

2. Pharmacy Prince of Wales Hospital Randwick NSW Australia

3. Department of Emergency Medicine, Clinical Toxicology Unit Prince of Wales Hospital Randwick NSW Australia

4. Biomedical Informatics and Digital Health University of Sydney NSW Australia

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.15448

Reference39 articles.

1. Therapeutic Goods Administration.Australian Public Assessment Report for Tapentadol Proprietary Product Name: Palexia IR. 2011;2021. Accessed July 1 2022.https://www.tga.gov.au/sites/default/files/auspar-palexia.pdf

2. Therapeutic Goods Administration.Australian Public Assessment Report for Tapentadol Proprietary Product Name: Palexia SR 2011;2021. Accessed July 1 2022.https://www.tga.gov.au/file/1393/download

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Wastewater‐based evaluation of the efficacy of oxycodone regulations in Australia;Addiction;2024-09-11

2. How is postoperative pain after hip and knee replacement managed? An analysis of two large hospitals in Australia;Perioperative Medicine;2024-05-31

3. A LC-MS/MS method for the simultaneous quantification of 17 opioids in biosolids;Talanta;2024-05

4. Quality use of publicly subsidised tapentadol in Australia: a population‐based analysis;Internal Medicine Journal;2024-02

5. Endogenous opiates and behavior: 2022;Peptides;2023-11